"Consequently, the Court also considered that it was appropriate to lift the interim measure under Rule 39 of its Rules of Court. The case concerned Charlie Gard, a baby suffering from a rare and fatal genetic disease. In February 2017, the treating hospital sought a declaration from the domestic courts as to whether it would be lawful to withdraw artificial ventilation and provide Charlie with palliative care. Charlie’s parents also asked the courts to consider whether it would be in the best interests of their son to undergo experimental treatment in the U.S.A.. The domestic courts concluded that it would be lawful for the hospital to withdraw life sustaining treatment because it was likely that Charlie would suffer significant harm if his present suffering was prolonged without any realistic prospect of improvement, and the experimental therapy would be of no effective benefit."